Report of Foreign Issuer (6-k)
September 18 2017 - 3:18PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For
the month of September 2017
Commission
File Number 001-37381
MEDIGUS
LTD.
(Translation of registrant’s name into English)
Omer
Industrial Park, No. 7A, P.O. Box 3030, Omer 8496500, Israel
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
EXPLANATORY
NOTE
On
September 18, 2017, Medigus Ltd., or Medigus, issued a press release titled: “Medigus Announces Second Quarter 2017 Financial
Results.” A copy of this press release, together with Medigus’ unaudited condensed consolidated interim financial
statements and its operating and financial review, as of June 30, 2017, and for the three months and six months then ended, are
furnished herewith as exhibits 99.1, 99.2 and 99.3, respectively.
This
Form 6-K, including Exhibits 99.2 and 99.3 but excluding Exhibit 99.1, is incorporated by reference into the Company’s Registration
Statement on Form F-3 filed with the Securities and Exchange Commission on August 24, 2016 (Registration No. 333-213280) and its
Registration Statement on Form S-8 filed with the Securities and Exchange Commission on September 8, 2015 (Registration No. 333-206803).
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
MEDIGUS
LTD.
|
|
|
|
Date:
September 18, 2017
|
By:
|
/s/
Oded Yatzkan
|
|
|
Oded
Yatzkan
|
|
|
Chief
Financial Officer
|
EXHIBIT
INDEX
4
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Apr 2024 to May 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From May 2023 to May 2024